Cargando…
Bone metabolism in Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is a rare disease of not well-defined etiology that involves immune cell activation and frequently affects the skeleton. Bone involvement in LCH usually presents in the form of osteolytic lesions along with low bone mineral density. Various molecules involved in b...
Autores principales: | Anastasilakis, Athanasios D, Tsoli, Marina, Kaltsas, Gregory, Makras, Polyzois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063875/ https://www.ncbi.nlm.nih.gov/pubmed/29967185 http://dx.doi.org/10.1530/EC-18-0186 |
Ejemplares similares
-
Adult Langerhans Cell Histiocytosis and the Skeleton
por: Georgakopoulou, Danae, et al.
Publicado: (2022) -
Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series
por: Chellapandian, Deepak, et al.
Publicado: (2016) -
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net
por: Girschikofsky, Michael, et al.
Publicado: (2013) -
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012) -
SUN-LB65 Circulating Micrornas Linked to Bone Metabolism Are Affected by Sequential Anti Osteoporotic Treatment in Postmenopausal Osteoporosis
por: Yavropoulou, Maria, et al.
Publicado: (2020)